Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial

Bogdan Marian Sorohan,Bogdan Obrișcă,Roxana Jurubiță,Gabriela Lupușoru,Camelia Achim,Andreea Andronesi,Georgiana Frățilă,Andreea Berechet,Georgia Micu,Gener Ismail
DOI: https://doi.org/10.1097/md.0000000000037475
IF: 1.6
2024-03-09
Medicine
Abstract:The kidney plays a central role in maintaining the acid-base balance by excreting acids, generating and reabsorbing bicarbonate. [ 1 ] Patients with chronic kidney disease (CKD) often develop metabolic acidosis(MA), which is defined as a serum bicarbonate level < 22 mmol/L. [ 2 ] The prevalence of MA in CKD increases with a decline in kidney function; thus, it can reach up to ~40% in stage 4 CKD. [ 3 ] Chronic MA is associated with several complications including cardiovascular events, insulin resistance, endothelial dysfunction, sarcopenia, bone mineral disorders, vascular calcification, and inflammation. [ 4 ] Moreover, MA has been shown to be an important risk factor for the progression of CKD. Recent data suggest that acidosis, even in the early stages of CKD, leads to progressive kidney dysfunction. [ 5 ]
medicine, general & internal
What problem does this paper attempt to address?